RV Systolic Pressure Estimation (RVSP)
Estimates right ventricular systolic pressure (RVSP) / pulmonary artery systolic pressure (PASP) from Doppler echocardiography using tricuspid regurgitation jet velocity. Normal PASP <35 mmHg.
Score interpretation
→ RVSP <35 mmHg: Normal. No pulmonary hypertension. Reassess if symptoms of dyspnoea or desaturation develop; repeat echo in 3–5 years or if clinical change.
→ RVSP 35–49 mmHg: Borderline/mild pulmonary hypertension. Investigate underlying cause (VHD, LV dysfunction, lung disease, CTEPH). Right heart catheterisation (RHC) for definitive diagnosis if pre-test probability high. Pulmonology/cardiology referral.
→ RVSP ≥50 mmHg: Significant pulmonary hypertension. Urgent pulmonary hypertension centre referral; RHC mandatory for diagnosis and vasoreactivity testing; initiate PH-specific therapy per ESC/ERS guidelines (ambrisentan, sildenafil, selexipag for PAH).
Interpretation bands for the RVSP Estimation. Apply clinical judgement and local guidance.
References
Related
Curated clinical cross-links plus same-class fallbacks.
- Dobutamine (Acute HF / Stress Echo) · Inotrope / Acute Heart Failure
- Selexipag · Pulmonary Arterial Hypertension
- Macitentan · Pulmonary Arterial Hypertension
- Sildenafil (Paediatric — PPHN / PAH) · PDE5 Inhibitor (Paediatric Pulmonary Hypertension)
- Enalapril (Paediatric Heart Failure / Hypertension) · ACE Inhibitor (Paediatric Heart Failure / Hypertension)
- Sildenafil · PDE5 Inhibitor — Pulmonary Arterial Hypertension
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.